New drugs leave IBS patients hopeful - WAFF-TV: News, Weather and Sports for Huntsville, AL

New drugs leave IBS patients hopeful

(Source: Raycom) (Source: Raycom)

Dr. Khurshid Yousuf is a Gastroenterologist in Decatur. We talked with him about 2 new drugs for I.B.S. 

Irritable bowel syndrome is the name given to a syndrome which afflicts about 45 million patients in this country.

He says it can affect 15 percent of the population. Symptoms can include abdominal pain, cramping, bloating, diarrhea, constipation, or both, or mucus in the stool. 

So who does it strike? "Women less than 45 years of age. And it is an affliction that causes a lot of hardship to these patients."

We talked with several IBS patients, non of them would go on camera, but they did tell us that going out to lunch or dinner, any type of socializing is out of the question. What that means for these patients, often enough, is being home bound. But hopes are high with two drugs recently approved by the Food And Drug Administration.

"One of them is an antibiotic. In fact Xifaxin and that antibiotic works mainly in the gut. And we have been using that medicine for different reasons also, but we found out that if you use it for Irritable Bowel Syndrome, especially in patients who are diarrhea predominant, it works...not in all of them, but some of them."

Viberzi works differently. "And it works by decreasing the diarrhea and improving the consistency of the stool."

The FDA maintains side effects of Viberzi were said to be constipation, abdominal pain, and nausea. Xifaxan included nausea and high blood levels of a liver enzyme.

Copyright 2015 WAFF. All rights reserved.

Report an error

Powered by Frankly